← All stories
Policy
Knight Therapeutics Announces Regulatory Approval of TAVALISSE® in Colombia
MONTREAL, Sept. 01, 2026 (GLOBE NEWSWIRE) — Knight Therapeutics Inc. (“Knight”) (TSX: GUD), a pan-American (ex-US) pharmaceutical company, announced today that it has received regulatory approval from INVIMA, the Colombian health regulatory…
Covered by 1 outlet
All coverage · 1 article